Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)
NCT01347073
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Urea Cycle Disorders
Interventions
DRUG:
HPN-100
Sponsor
Amgen